Quick Answer
FENNEC PHARMACEUTICALS INC. reported Stockholders Equity of $35.47 million for the year ending 2025.
- FENNEC PHARMACEUTICALS INC. showed an increase of +704.1% in Stockholders Equity from 2024 to 2025.
- This data is from FENNEC PHARMACEUTICALS INC.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2008 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2015: $1.02 million | Q1 2016: $243.0 thousand | Q2 2016: $4.65 million | Q3 2016: $4.22 million | Q1 2017: $2.86 million | Q2 2017: $9.68 million | Q3 2017: $8.86 million | Q1 2018: $25.66 million | Q2 2018: $24.86 million | Q3 2018: $22.86 million | Q1 2019: $19.21 million | Q2 2019: $16.48 million | Q3 2019: $15.00 million | Q1 2020: $8.46 million | Q2 2020: $36.13 million | Q3 2020: $31.19 million | Q1 2021: $24.93 million | Q2 2021: $22.28 million | Q3 2021: $19.01 million | Q1 2022: $12.52 million | Q2 2022: $8.54 million | Q3 2022: $2.80 million | Q1 2023: -$7.34 million | Q2 2023: -$9.73 million | Q3 2023: -$10.53 million | Q1 2024: $3.01 million | Q2 2024: -$1.36 million | Q3 2024: -$5.17 million | Q1 2025: -$5.88 million | Q2 2025: -$7.46 million | Q3 2025: -$4.49 million.
- Over the full 19 years of available data (2008 to 2025), FENNEC PHARMACEUTICALS INC.'s Stockholders Equity has grown by 1,061.9%.
- Historical annual values: Fiscal year 2025: $35.47 million | Fiscal year 2024: -$5.87 million | Fiscal year 2023: -$11.62 million | Fiscal year 2023: $9.58 million | Fiscal year 2022: -$2.57 million | Fiscal year 2021: $15.77 million | Fiscal year 2020: $29.07 million | Fiscal year 2019: $11.88 million | Fiscal year 2018: $21.31 million | Fiscal year 2017: $26.76 million | Fiscal year 2016: $3.57 million | Fiscal year 2015: $548.0 thousand | Fiscal year 2014: $613.0 thousand | Fiscal year 2013: -$1.46 million | Fiscal year 2012: -$4.96 million | Fiscal year 2011: -$119.0 thousand | Fiscal year 2010: -$4.93 million | Fiscal year 2009: $406.0 thousand | Fiscal year 2008: $3.05 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: